Nathan Wymer

Nathan Wymer is a highly experienced scientist with a strong background in biochemistry and chemistry, specializing in process development for therapeutic applications. Currently serving as Principal Scientist at Life Edit Therapeutics since December 2022, Nathan focuses on downstream process development for AAV therapeutics. Prior experience includes roles as Scientist II at KBI Biopharma, where Nathan developed biomolecule purification processes, and as Assistant Professor at North Carolina Central University, delivering organic chemistry and biochemistry courses while conducting research on protein engineering. Nathan's extensive experience also includes significant contributions at Pfizer, Inc. as Principal Scientist in vaccine production technologies, and as a Scientist at zuChem, Inc., researching synthetic routes for carbohydrates. Nathan’s academic credentials include a PhD in Chemistry from Duke University and a BS in Chemistry from Purdue University, complemented by postdoctoral research at Georgia Institute of Technology.